Xilio Therapeutics (XLO) announced the appointment of Caroline Hensley as chief legal officer. Hensley most recently served as senior vice president, assistant general counsel and chief compliance officer at Seres Therapeutics (MCRB).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XLO:
- Xilio Therapeutics Reports Q3 2024 Progress and Financials
- Xilio Therapeutics Advances Cancer Drug and Financial Outlook
- Xilio Therapeutics announces initial data from Phase 1C trial for XTX101
- Xilio Therapeutics expects cash to fund operations into Q2 of 2025
- Xilio Therapeutics reports Q3 EPS (22c), consensus (25c)